Here are relevant reports on : human-resources-hiring-market
-
Probiotic Ingredients Market by Application (Functional Foods & Beverages, Pharmaceuticals, and Animal Nutrition), Source (Bacteria and Yeast), Form (Dry and Liquid), End User (Human and Animal), and Region - Global Forecast to 2023
The probiotic ingredients market is projected to grow from USD 268 million in 2018 to USD 402 million by 2023, at a compound annual growth rate (CAGR) of 8.5% during the forecast period. The increasing demand for dietary supplements in the pharmaceuticals, cosmetics, and personal care industries is projected to drive the market for probiotics, which in turn, is projected to drive the market growth for probiotic ingredients.
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
North America Human Microbiome Market By Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
North America Human Microbiome market, valued at US$0.43 billion in 2024, stood at US$0.78 billion in 2025 and is projected to advance at a resilient CAGR of 32.2% from 2025 to 2031, culminating in a forecasted valuation of US$4.15 billion by the end of the period. New startups in the US and Canada are driving innovation across microbiome therapeutics and diagnostics.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Power SCADA Market by Architecture (Hardware, Software, Services), Component (Remote Terminal Unit, Programmable Logic Controller, Human Machine Interface, Communication Systems, Protection relays, MTU), End User and Region - Global Forecast to 2028
The power SCADA market is projected to reach USD 2.9 billion by 2028, a notable compound annual growth rate (CAGR) of 7.1% during the forecast period. Key players in the global power SCADA market include ABB (Switzerland), Rockwell Automation (US), Siemens (Germany), Schneider Electric (France), and Emerson (US).
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Disclosure Management Market by Business Function (Finance, Legal, Marketing and Communication, Compliance, Procurement, and Human Resource), Component (Software and Services), Deployment Type, Organization Size, and Vertical - Global forecast to 2022
The disclosure management market accounted for USD 433.0 Million in 2016 and is projected to reach USD 1,066.0 Million by 2022, growing at a Compound Annual Growth Rate (CAGR) of 16.7% during 2017–2022. The major growth drivers of the disclosure management market include the increasing need to comply with regulatory bodies, and globalization of businesses. The base year considered for this report is 2016, and the market forecast period considered is 2017–2022. The major vendors providing disclosure management software and services are SAP (Germany), Oracle (US), Certent (US), IRIS Business Services (India), Workiva (US), CoreFiling (UK), DataTracks (India), LucaNet (Germany), OCR Services (US), Trintech (Australia), and Lecorpio (US).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
North America Probiotics Market by Product Type (Functional Food & Beverages, Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel, and Region - Forecast to 2030
The North America probiotics market is estimated to be USD 14.78 billion in 2025 and is projected to reach USD 21.92 billion by 2030, at a CAGR of 8.2% from 2025 to 2030. The Key ADM (US), Probi USA Inc. (US), Danone North America Public Benefit Corporation (US), International Flavors & Fragrances Inc. (US), Nestle USA (US), Lifeway Foods, Inc. (US), Lactalis American Group, Inc. (US), Kerry Group plc. (Ireland), Now Foods (US), Nature’s Bounty (US), Renewlife (US), Garden of Life (US), Jarrow Formulas, Inc. (US), Kevita (US), and Chobani, LLC. (US).
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Fish Oil Market for Aquaculture, Direct Human Consumption, Hydrogenation & Industrial Applications - Industry Analysis, Size, Share, Growth, Trends & Forecast, 2012 - 2018
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Cell Expansion Market by Product (Consumables (Media, Sera, Reagents, Vessels), Equipment (Cell Expansion Systems, Bioreactors, Incubators)), Cell Type (Human, Animal (CHO, mESCs)), Application (Vaccines, mAbs, CGT), End User - Global Forecast to 2029
The global cell expansion market, valued at US$12.7 billion in 2023, stood at US$14.3 billion in 2024 and is projected to advance at a resilient CAGR of 13.3% from 2024 to 2029, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth of the cell expansion market can be attributed to factors such as the booming biopharmaceutical industry, increased investments in research and development for the advancement of biopharmaceutical industry, rising need of advanced biopharmaceuticals, and increasing GMP certification for cell therapy manufacturing facilities.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Human Microbiome Drugs Market by Type (Live Biotherapeutic Products, Fecal Microbiota-derived Therapeutics), Disease (Gastrointestinal, Infectious), End User (Hospitals, Clinics, Long-term Care) - Global Forecast to 2031
The human microbiome drugs market, valued at US$0.09 billion in 2024, stood at US$0.35 billion in 2025 and is projected to advance at a resilient CAGR of 35.2% from 2025 to 2031, culminating in a forecasted valuation of US$2.13 billion by the end of the period. The human microbiome drugs market is growing, driven by the increasing clinical success of live biotherapeutic products, rising prevalence of chronic and recurrent diseases, and expanding therapeutic applications beyond gastrointestinal disorders into metabolic, immune, and neurological conditions.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Europe Human Microbiome Market by Drug & Supplement (Drugs, Probiotics, Prebiotics, Synbiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Disease), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
The Europe Human Microbiome Market, valued at US$0.22 billion in 2024, stood at US$0.29 billion in 2025 and is projected to advance at a resilient CAGR of 28.6% from 2025 to 2031, culminating in a forecasted valuation of US$1.31 billion by the end of the period. The growth of the Europe human microbiome market is driven by increased awareness of personalized health, the adoption of microbiome-based therapies, and advancements in sequencing technologies and bioinformatics.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Non-Human Identity (NHI) Access Management Market by Identity Type (Application-to-Application & API Identities, Machine & Device Identities, Cryptographic Access Identities), Deployment Mode (Cloud, On-Premises, Hybrid) - Global Forecast to 2030
The non-human identity (NHI) access management market is projected to grow from USD 9.45 billion in 2024 to USD 18.71 billion by 2030, registering a CAGR of 11.9% during the forecast period. The key players include Microsoft (US), Amazon Web Services (US), Google (US), Okta (US), Ping Identity (US), IBM (US), Oracle (US), CyberArk (US), HashiCorp (US), Aembit (US), Red Hat (US), Thales (France), Entrust (US), and Kong (US).
- Published: September 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
